Stocks and Finance

Targacept

Targacept 4/30/2012

09:33 : Targacept, AstraZeneca end partnership on failed drug - AstraZeneca PLC has formally notified Targacept Inc. that it will dissolve its collaboration and license agreement for the anti-depression drug TC-5214 that they had been working on together. That drug failed in Phase 3 clinical trials ...
Source : bizjournals-com

Targacept 4/27/2012

09:53 : CEO of Targacept partner AstraZeneca resigns - The recent failure of Targacept's antidepression drug TC-5214 in clinical trials, which led the Winston-Salem company to shed half its workforce this week, may have also contributed to the downfall of the CEO of Targacept's development partner on that ...
Source : bizjournals-com

Targacept 4/25/2012

15:59 : McConnell: Targacept downsizing not a concern - Dr. John McConnell, CEO of Wake Forest Baptist Medical Center, said he does not believe the downsizing at anchor tenant Targacept Inc. will have a lasting negative impact on the Piedmont Triad Research Park. Targacept ...
Source : bizjournals-com
08:56 : Targacept cutting its workforce in half - Biotechnology firm Targacept Inc. will lay off 65 employees — or about 46 percent of its workforce of 142 people — following the failure of what had been its most advanced drug candidate, In an announcement, CEO Don deBethizy said the ...
Source : bizjournals-com

Targacept 3/20/2012

12:51 : Targacept implodes on drug failure - BOSTON (MarketWatch) -- Shares of Targacept Inc. plunged 28% to $5.36 Tuesday after the biotech group said that a Phase III clinical trial of its antidepressant TC-5214 showed the drug was largely ineffective in treating major depressive ...
Source : marketwatch-com

Targacept 12/5/2011

11:52 : Targacept launching new trials for schizophrenia, ADHD drug - Targacept will launch two new Phase 2 clinical trials of a drug known as TC-5619 as a potential treatment for both schizophrenia and attention deficit/hyperactivity disorder, according to an announcement. Earlier clinical research has ...
Source : bizjournals-com

Targacept 11/8/2011

11:43 : Targacept implodes on failed drug study - BOSTON (MarketWatch) -- Shares of Targacept Inc. tumbled 57% to $8.20 Tuesday morning on news that initial results from a Phase III study for its antidepressant TC-5214 failed to show it was effective in treating ...
Source : marketwatch-com
07:17 : Targacept (TRGT) and AstraZeneca (AZN) announce their experimental depress - Targacept (TRGT) and AstraZeneca (AZN) announce their experimental depression pill failed to show any improvement for patients in a clinical trial. The firms are studying TC-5214 as a potential additional therapy for patients no longer ...
Source : seekingalpha-com
actualidad Targacept -


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts